Lyra Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 56
Rang # Quantité totale PI 24 466
Note d'activité PI 2,4/5.0    33
Rang # Activité PI 23 237
Symbole boursier LYRA (nasdaq)
ISIN US55234L1052
Capitalisation 14.10M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

40 1
11 0
4 0
0
 
Dernier brevet 2024 - Implantable scaffolds for treatm...
Premier brevet 2009 - Polymeric implant delivery system
Dernière marque 2024 - XTREO
Première marque 2024 - XTREO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceuticals for the treatment of nose and sinus and respiratory related conditions and symptoms.
Invention Implantable scaffolds for treatment of sinusitis. This disclosure describes, inter alia, materia...
Invention Implantable matrix for treating central nervous system disorders. The present invention is relat...
2023 Invention Implantable scaffolds for treatment of sinusitus. This disclosure describes, inter alia, materia...
Invention Implantable corticosteroid matrix for sinus condition. The present invention relates to material...
Invention Scaffold loading and delivery systems. This disclosure describes, inter alia, materials, devices...
Invention Osmotic drug delivery implants. The present invention relates to implantable devices, as well as...
Invention Assessing the response to treatment of sinusitis. This disclosure describes, inter alia, materia...
Invention Implantable scaffolds for treatment of sinusitis. This disclosure describes, inter alia, material...
2022 Invention Implantable matrix for treating central nervous system disorders. The present invention is relate...
Invention Implantable corticosteroid matrix for sinus condition. The present invention relates to materials...
2021 Invention Osmotic drug delivery implants. The present invention relates to implantable devices, as well as ...
Invention Assessing the response to treatment of sinusitis. This disclosure describes, inter alia, material...
Invention Scaffold loading and delivery systems. This disclosure pertains, inter alia, to scaffold loading...
2020 Invention Implantable scaffolds for treatment methods of sinusitus. This disclosure describes various sinus...
Invention Drug-eluting medical implants. Disclosed are self-expanding medical implants for placement withi...
Invention Implantable scaffolds for treatment of sinusitis and method of reducing inflammation. This disclo...
2018 Invention Implantable scaffolds for treatment of sinusitus. This disclosure describes various sinus scaffol...
Invention Scaffold loading and delivery systems. This disclosure describes, inter alia, materials, devices,...
Invention Drug eluting medical implant. Disclosed are self-expanding medical implants for placement within ...
2017 Invention Drug-eluting medical implants. Disclosed are self-expanding medical implants for placement within...
Invention Implantable scaffolds and methods for treatment of sinusitis. This disclosure describes, inter al...
Invention Drug-eluting medical implants. Disclosed are medical implants for placement within a lumen of a p...
2016 Invention Scaffold loading and delivery systems. This disclosure pertains, inter alia, to scaffold loading ...
2013 Invention Stent delivery system. Delivery systems for polymeric tubular implants, kits that include such de...
Invention Medical implants. Disclosed are self-expanding medical implants for placement within a lumen of a...
2012 Invention Polymeric implant delivery system. Delivery systems for a polymeric tubular implant, kits that in...
Invention Medical implant. Disclosed is a self-expanding medical implant for placement within a lumen of a ...
2011 Invention Bioresorbable thermoset polyester/urethane elastomers. Bioresorbable thermoset elastomers and met...